These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Gene transfer as an approach to treating hemophilia. High KA Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573 [TBL] [Abstract][Full Text] [Related]
27. Gene transfer in the hemophilias: retrospect and prospect. Brinkhous KM Thromb Res; 1992 Aug; 67(3):329-38. PubMed ID: 1412215 [No Abstract] [Full Text] [Related]
28. Gene therapy progress and prospects: gene therapy for the hemophilias. Walsh CE Gene Ther; 2003 Jun; 10(12):999-1003. PubMed ID: 12776156 [TBL] [Abstract][Full Text] [Related]
30. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences. Chuah M; Vandendriessche T Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211 [TBL] [Abstract][Full Text] [Related]
34. Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation. Herzog RW; Mount JD; Arruda VR; High KA; Lothrop CD Mol Ther; 2001 Sep; 4(3):192-200. PubMed ID: 11545609 [TBL] [Abstract][Full Text] [Related]
35. Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives. Chernyi N; Gavrilova D; Saruhanyan M; Oloruntimehin ES; Karabelsky A; Bezsonov E; Malogolovkin A Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062568 [TBL] [Abstract][Full Text] [Related]